CORDIS
EU research results

CORDIS

English EN
Demonstration of solvent and resin production from lignocellulosic biomass via the platform chemical levulinic acid

Demonstration of solvent and resin production from lignocellulosic biomass via the platform chemical levulinic acid

Objective

The GreenSolRes-Project demonstrates the levulinic acid value chain of lignocellulosic feedstocks to high-value products in a 3-step approach on TRL 6 to 7: First, a demonstration plant in Biorefinery of RWTH Aachen will be designed and build according to GFBiochemicals proprietary technology for conversion of lignocellulosic biomass to the platform chemical levulinic acid. Levulinic acid hydrolysate separation at GFB’s technology provider enables more efficient and purer levulinic acid production. In a 2nd step the versatile platform chemical levulinic acid is hydrogenated to 2-methyltetrathydrofuran (2-MTHF), gamma-valerolactone (GVL) and 1-methyl-1,4-butanediol (MeBDO) in a direct process developed by RWTH Aachen. These can be produced in the same reactor with a single catalyst by tuning the process conditions, the demo-plant is constructed by GFB. Third, the application of the products as solvents is validated in adhesives and the pharma sector as substitute of their more ecotoxic C4-analogues. Additionally, HENKEL studies the development of respective new polymers with improved properties. The basic engineering of first commercial plants for these steps supports rapid upscaling and exploitation after the project. This will release these products from the niche markets they are confined to due to ineffective existing production routes. At competitive prices compared to their petrochemical C4-counterparts these chemicals and related products will boost the bio-based market as they have a high GHG avoidance of at least 70% and an additional value to society via better health & safety properties. The whole value chain from e.g. forestry residues to consumer products is assessed for environmental sustainability, risks and health & safety to support business case development and market implementation.

Coordinator

GFB EUROPE BV

Address

Burg Lemmensstraat 358
6163 Jt Geleen

Netherlands

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 2 028 686,45

Participants (7)

Sort alphabetically

Sort by EU Contribution

Expand all

HENKEL KGaA

Germany

EU Contribution

€ 626 887,50

RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN

Germany

EU Contribution

€ 3 064 500

LEIBNIZ - INSTITUT FUR KATALYSE EV AN DER UNIVERSITAT ROSTOCK

Germany

EU Contribution

€ 797 562,50

SYNCOM FORSCHUNGS- UND ENTWICKLUNGSBERATUNG GMBH

Germany

EU Contribution

€ 396 862,49

HYBRID CATALYSIS BV

Netherlands

EU Contribution

€ 360 981,68

VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V.

Belgium

EU Contribution

€ 176 465

GFBIOCHEMICALS ITALY SPA

Italy

Project information

Grant agreement ID: 720695

Status

Ongoing project

  • Start date

    1 September 2016

  • End date

    31 August 2021

Funded under:

H2020-EU.3.2.6.

  • Overall budget:

    € 8 938 660,54

  • EU contribution

    € 7 451 945,62

Coordinated by:

GFB EUROPE BV

Netherlands